Home > Boards > Canadian > Telecommunications Networks > Synchronica (LSE:SYNC)

Been looking at the Times of London on

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Telco Geek Member Profile
 
Followed By 0
Posts 3
Boards Moderated 0
Alias Born 02/04/12
160x600 placeholder
Syncona director and CIO sell GBP1.6 million in shares Alliance News - 4/6/2021 12:26:21 PM
*Syncona Non-Exec Henderson's associate sells 317,961 shares at GBP2.50 each Alliance News - 4/6/2021 11:05:03 AM
Syncona Limited Director/PDMR Shareholding UK Regulatory (RNS & others) - 4/6/2021 11:00:00 AM
4D Pharma loss widens on rise in administrative costs Alliance News - 4/1/2021 7:00:28 AM
Syncona Limited Freeline Reports Financial Results UK Regulatory (RNS & others) - 4/1/2021 2:00:00 AM
Syncona says Achilles stake leaps to GBP145 million value after IPO Alliance News - 3/31/2021 4:18:39 AM
Syncona Limited Achilles update on IPO UK Regulatory (RNS & others) - 3/31/2021 2:00:00 AM
Gym Group directors sell GBP1.8 million in shares Alliance News - 3/30/2021 11:01:59 AM
Syncona Limited Director/PDMR Shareholding UK Regulatory (RNS & others) - 3/30/2021 7:04:00 AM
Syncona invests USD42 million into Gyroscope to have 54% stake Alliance News - 3/26/2021 5:20:54 AM
Syncona Limited Gyroscope announces additional financing plans UK Regulatory (RNS & others) - 3/26/2021 3:06:00 AM
Syncona Limited Syncona cornerstones $148m Series C in Gyroscope UK Regulatory (RNS & others) - 3/26/2021 3:00:00 AM
Syncona portfolio firm Achilles Therapeutics prices US share offering Alliance News - 3/25/2021 8:23:28 AM
Syncona Limited Update on Achilles' proposed IPO UK Regulatory (RNS & others) - 3/25/2021 7:13:00 AM
Origin Enterprises loss slims; Amryt issues guidance Alliance News - 3/4/2021 7:46:53 AM
Syncona Limited Autolus Reports Full Year 2020 Financial Results UK Regulatory (RNS & others) - 3/4/2021 7:10:00 AM
Syncona investee Achilles Therapeutics files for US IPO Alliance News - 3/2/2021 8:45:33 AM
Syncona Limited Achilles files registration statement UK Regulatory (RNS & others) - 3/2/2021 2:00:00 AM
Syncona's Gyroscope Reports Positive Results From GT005 Test Alliance News - 2/12/2021 11:24:43 AM
Syncona Limited Gyroscope Announces Positive Interim Data UK Regulatory (RNS & others) - 2/12/2021 10:49:00 AM
Syncona Net Asset Value Dips In Third Quarter, Invests More In Quell Alliance News - 2/11/2021 5:05:20 AM
Syncona Limited Quarterly and Business Update UK Regulatory (RNS & others) - 2/11/2021 2:00:00 AM
Syncona Limited New commitment to Quell in largest ever Series A UK Regulatory (RNS & others) - 2/11/2021 2:00:00 AM
Syncona Investee Autolus Nets USD100 Million From ADS Offer Alliance News - 2/10/2021 4:41:45 AM
Syncona Limited Autolus announces pricing of public offering UK Regulatory (RNS & others) - 2/10/2021 2:00:00 AM
Telco Geek   Friday, 02/24/12 05:00:04 AM
Re: None
Post # of 9 

Been looking at the Times of London on the flight over. Looks like the CEO of TSXV listed Synchronica has been caught insider dealing...


Synchronica Mobile Chief Purchased Shares After Swiss Takeover Approach

Nic Fildes, Gary Parkinson

The chief executive of the Synchronica mobile messaging company bought 800,000 shares in the business three weeks after it received a takeover approach that it had not revealed to the market.

Angus Dent spent £490,000 on the shares on November 30 at 6.125p each. The shares have since doubled to 12.4p largely as a result of an approach from rival Myriad regarding a possible takeover. Synchronica issued that statement on January 3.

However, the offer document posted on the website of Myriad, a Swiss company, shows that it first approached its British rival on November 10.

Mr Dent told The Times that the two businesses had met earlier in 2011 at the company’s offices in Tunbridge Wells. He said that the company then received a letter in early November that constituted “a vague approach” that was firmly rebuffed.

Mr Dent said that he assumed the approach had gone cold when he moved to buy shares and that he cleared the stock purchase with the company’s nominated adviser Northland Capital Partners, which told Mr Dent to check with executive chairman David Mason before acting. “We had a five to ten minute chat and agreed it would be appropriate,” Mr Dent said.

However, Myriad came back two days later with a fresh offer. “We thought Myriad had come on another fishing expedition,” he said. Yet Myriad’s interest proved genuine as it made a £20.6 million offer, which it revealed in what Mr Dent described as a “rather silly announcement”.

Synchronica has repeatedly urged its shareholders to reject its Swiss rival on the basis that the offer undervalued the shares of the British company. Mr Dent defended his stock purchase. “You can only act on what you know at the time,” he said. He bought the stock because he believed that the company was “massively undervalued” and that its shares have historically risen toward the end of the year.

Synchronica experienced a turbulent 2011. FinnCap, its nominated adviser, decided to step back from offering advice to the company earlier in the year. Then its co-founders Carsten Brinkschulte and Nicole Meissner, respectively chief executive and chief operating officer, quit the company in September.


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences